Control of Metastases via Myeloid CD39 and NK Cell Effector Function
Juming Yan(Xuzhou Medical College), Mark J. Smyth(Peter MacCallum Cancer Centre), Courtney Beers(Rapt Therapeutics (United States)), Simon C. Robson(Beth Israel Deaconess Medical Center), Bianca Nowlan(QIMR Berghofer Medical Research Institute), Nishamol Geetha(QIMR Berghofer Medical Research Institute), Achim K. Moesta(Rapt Therapeutics (United States)), Xian-Yang Li(QIMR Berghofer Medical Research Institute), Célia Jacoberger-Foissac(Institute for Research in Immunology and Cancer), Michele W.L. Teng(The University of Queensland), Christos Xiao(QIMR Berghofer Medical Research Institute), Amelia Roman Aguilera(QIMR Berghofer Medical Research Institute)
Cited by 81
Related Papers
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
|The Journal of Experimental Medicine|2007|2.4k
Immune surveillance of tumors
|Journal of Clinical Investigation|2007|1.4k
Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial
|Annals of Oncology|2014|1.3k
Negative feedback control of neuronal activity by microglia
|Nature|2020|997
The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance
|Purinergic Signalling|2006|928